Maternal-Fetal Evidence Based Guidelines

Vincenzo Berghella, MD, FACOG, is Director of the Division of Maternal-Fetal Medicine and Professor in the Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA. A former President of the Society for Maternal-Fetal Medicine, he is also on the Editorial Board of the Journal of Maternal Fetal and Neonatal Medicine, of the British Journal of Obstetrics and Gynecology, and Associate Editor of American Journal of Obstetrics and Gynecology. He is also Associate Editor for the Cochrane Review and Oral Examiner for American Board of Obstetrics and Gynecology: Maternal-Fetal Medicine.

Hypertensive disorders. Cardiac disease. Obesity. Pregestational diabetes. Gestational diabetes. Hypothyroidism. Hyperthyroidism. Prolactinoma. Nausea/vomiting of pregnancy and hyperemesis gravidarum. Intrahepatic cholestasis of pregnancy. Inflammatory bowel disease. Gallbladder disease. Pregnancy after liver and other transplantation. Maternal anemia. Sickle cell disease. von Willebrand disease. Renal disease. Headache. Seizures.
Spinal cord injury. Mood disorders. Smoking. Drug abuse. Respiratory diseases: asthma, pneumonia, influenza, and tuberculosis. Systemic lupus erythematosus. Antiphospholipid syndrome. Inherited thrombophilia. Venous thromboembolism and anticoagulation. Hepatitis A. Hepatitis B. Hepatitis C. HIV. Gonorrhea. Chlamydia. Syphilis. Trichomonas. Group B Streptococcus. Vaccination. Trauma. Critical care. Amniotic fluid embolism. Cancer. Dermatoses of pregnancy. Multiple gestations. Fetal growth restriction. Fetal macrosomia. Cytomegalovirus. Toxoplasmosis. Parvovirus. Herpes. Varicella. Fetal and neonatal alloimmune thrombocytopenia. Hemolytic disease of the fetus/neonate. Nonimmune hydrops fetalis. Fetal death. Antepartum testing. Sonographic assessment of amniotic fluid: oligohydramnios and polyhydramnios. Fetal maturity testing.